Daniel Flesch

Title: The Innovative Contributions of Daniel Flesch

Introduction

Daniel Flesch is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in immune-related diseases. His work is characterized by a commitment to advancing medical science through innovative solutions.

Latest Patents

Daniel Flesch holds a patent for a compound titled "Competitive PPAR-gamma antagonists." This invention pertains to a new compound, E)-2-(5-((4-methoxy-2-(trifluoromethyl)quinolin-6-yl)methoxy)-2-((4-(trifluoromethyl) benzyl)oxy)-benzylidene) hexanoic acid (MTTB), and its derivatives. The compounds developed in this patent are useful as selective peroxisome proliferator-activated receptor gamma (PPARγ) antagonists. They are indicated for use in the treatment of immune-related diseases such as systemic inflammation, sepsis, and septic shock. Daniel Flesch has 1 patent to his name.

Career Highlights

Daniel Flesch is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research institution in applied sciences. His work at this esteemed organization has allowed him to focus on innovative research that has the potential to impact healthcare significantly.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues such as Andreas Von Knethen and Manfred Schubert-Zsilavecz. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Daniel Flesch's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of critical health issues.